Mofegiline (MDL-72,974) is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B) and semicarbazide-sensitive amine oxidase (SSAO) which was under investigation for the treatment of Parkinson's disease and Alzheimer's disease, but was never marketed. See also Ladostigil Lazabemide Rasagiline Selegiline References Abandoned drugs Antidementia agents Antiparkinsonian agents Monoamine oxidase inhibitors